Lista de obras - Ilaria Vicenti - Dominio Público Uruguay

A unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses

artículo científico publicado en 2020

Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.

artículo científico publicado en 2017

Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection

artículo científico publicado en 2020

Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses

artículo científico publicado en 2021

Comparable In Vitro Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations

artículo científico publicado en 2019

Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro

artículo científico publicado en 2017

Detection of residual human immunodeficiency virus type 1 reverse transcriptase K103N minority species in plasma RNA and peripheral blood mononuclear cell DNA following discontinuation of non-nucleoside therapy.

artículo científico publicado en 2009

Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication

artículo científico publicado en 2020

Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood

artículo científico publicado en 2017

Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia

artículo científico publicado en 2018

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors

scientific article published on 19 July 2019

Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients

artículo científico publicado en 2016

Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro

scientific article published on 10 January 2020

Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters

artículo científico publicado en 2006

Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent Inhibitor

scientific article published on 09 April 2020

Frequent detection of antiretroviral drug resistance in HIV-1-infected orphaned children followed at a donor-funded rural pediatric clinic in Dodoma, Tanzania

artículo científico publicado en 2014

Front Cover: Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses (ChemMedChem 23/2021)

artículo científico publicado en 2021

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

artículo científico publicado en 2017

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database

artículo científico publicado en 2016

Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing

artículo científico publicado en 2010

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants

scholarly article

In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations

scientific article published on 24 September 2020

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice

scientific article published on 22 February 2019

Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR.

artículo científico publicado en 2015

Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells

scientific article published on 13 October 2020

Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic

artículo científico publicado en 2020

Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy

artículo científico publicado en 2007

Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy

artículo científico publicado en 2012

Near full-length sequence analysis of HIV type 1 BF recombinants from Italy

artículo científico publicado en 2011

Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage

artículo científico publicado en 2023

No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference

scientific article published on 17 October 2019

Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A

article

Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses

scientific article published in 2023

Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA

artículo científico publicado en 2020

Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort

artículo científico publicado en 2018

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

artículo científico publicado en 2019

Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing

article

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

article

SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility

artículo científico publicado en 2022

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

scholarly article by Ilaria Vicenti published in 2021

Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro

artículo científico publicado en 2021

Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism

artículo científico publicado en 2013

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

artículo científico publicado en 2020

The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro

artículo científico publicado en 2017

The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro

article

Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple

artículo científico publicado en 2008

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors

artículo científico publicado en 2015

Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects

artículo científico publicado en 2007

Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012

artículo científico publicado en 2020

Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012

artículo científico publicado en 2020

Lista de obras de Ilaria Vicenti

A unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses

Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.

Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection

Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses

Comparable In Vitro Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations

Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro

Detection of residual human immunodeficiency virus type 1 reverse transcriptase K103N minority species in plasma RNA and peripheral blood mononuclear cell DNA following discontinuation of non-nucleoside therapy.

Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication

Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood

Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors

Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients

Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro

Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters

Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent Inhibitor

Frequent detection of antiretroviral drug resistance in HIV-1-infected orphaned children followed at a donor-funded rural pediatric clinic in Dodoma, Tanzania

Front Cover: Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses (ChemMedChem 23/2021)

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database

Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants

In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice

Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR.

Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells

Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic

Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy

Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy

Near full-length sequence analysis of HIV type 1 BF recombinants from Italy

Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage

No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference

Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A

Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses

Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA

Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro

Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro

The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro

Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors

Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects

Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012

Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012